How can lung cancer be prevented?
- Lung cancer is the number-one cause of cancer deaths in both men and women in the U.S. and worldwide.
- Cigarette smoking is the principal risk factor for development of lung cancer.
- Passive exposure to tobacco smoke also can cause lung cancer.
- The two types of lung cancer, which grow and spread differently, are the small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC).
- The stage of lung cancer refers to the extent to which the cancer has spread in the body.
- Treatment of lung cancer can involve a combination of surgery, chemotherapy, and radiation therapy as well as newer experimental methods.
- The general prognosis of lung cancer is poor, with overall survival rates of about 16% at five years.
- Smoking cessation is the most important measure that can prevent the development of lung cancer.
Additional resources from WebMD Boots UK on
Lung Cancer
REFERENCES:
Hung, R.J., et al. A Susceptibility Locus for Lung Cancer Maps to Nicotinic Acetylcholine Receptor Subunit Genes on 15q25." Nature 452.7187 Apr. 3, 2008: 633-637.
McKeage, Mark J., et al. "Phase II Study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800 mg/m2 Combined With Carboplatin and Paclitaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer." Lung Cancer 65.2 Aug. 2009: 192-197.
United States. National Cancer Institute (NCI). "Lung Cancer." July 26, 2007. <http://www.cancer.gov/cancertopics/types/lung>.
"What Are the Key Statistics About Lung Cancer?" American Cancer Society. Oct. 20, 2009. <http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About _Lung_Cancer_15.asp?sitearea=>.
"What You Need to Know About Lung Cancer." National Cancer Institute, U.S. National Institutes of Health. July 26, 2007. <http://www.cancer.gov/cancertopics/types/lung>.
Hung, R.J., et al. A Susceptibility Locus for Lung Cancer Maps to Nicotinic Acetylcholine Receptor Subunit Genes on 15q25." Nature 452.7187 Apr. 3, 2008: 633-637.
McKeage, Mark J., et al. "Phase II Study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800 mg/m2 Combined With Carboplatin and Paclitaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer." Lung Cancer 65.2 Aug. 2009: 192-197.
United States. National Cancer Institute (NCI). "Lung Cancer." July 26, 2007. <http://www.cancer.gov/cancertopics/types/lung>.
"What Are the Key Statistics About Lung Cancer?" American Cancer Society. Oct. 20, 2009. <http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About _Lung_Cancer_15.asp?sitearea=>.
"What You Need to Know About Lung Cancer." National Cancer Institute, U.S. National Institutes of Health. July 26, 2007. <http://www.cancer.gov/cancertopics/types/lung>.
Aucun commentaire:
Enregistrer un commentaire